| |
Basal levels treatment
|
After 6 days of D-Asp treatment
|
After 12 days of D-Asp
|
3 days after the suspension of D-Asp
|
|---|
| |
LH
(mIU/ml serum)
|
|
Subjects treated with with Na-D-aspartate
|
4.2 ± 0.5
|
4.5 ± 0.6
|
5.6 ± 0.9*
|
4.8 ± 0.8
|
|
Subjects treated with placebo
|
4.2 ± 0.4
|
4.3 ± 0.7
|
4.2 ± 0.6
|
4.1 ± 0.5
|
| |
Testosterone
(ng/ml serum)
|
|
Subjects treated with Na-D-aspartate
|
4.5 ± 0.6
|
5.2 ± 0.7
|
6.4 ± 0.8*
|
5.8 ± 0.6*
|
|
Subjects treated with placebo
|
4.6 ± 0.5
|
4.5 ± 0.7
|
4.7 ± 0.7
|
4.6 ± 0.7
|
- These results are the mean ± SEM of LH and testosterone in serum of 23 participants (aged 27-37 years) at zero time (basal levels), after 6 days and 12 days of D-aspartate treatment and 3 days after the suspension of treatment. Subjects drank a daily dose of DADAVIT® (Na-D-aspartate). The placebo treatment was carried out on another 20 participants of the same age, who drank a daily dose of DADAVIT® placebo. Statistical analysis was conducted using ANOVA with repeated measures (post-hoc test). * Values are statistically significant for p < 0.001.
